Philidelphia, US - 29 June 2023 - Pharmaceutical thermal protection specialist Tower Cold Chain has opened its new...
Philidelphia, US - 29 June 2023 - Pharmaceutical thermal protection specialist Tower Cold Chain has opened its new...
Basingstoke, UK - 28 June 2023 - Eli Lilly and Company announced today that the Medicines and Healthcare products...
London, UK - 28th June 2023 - Sciad Newswire - Hosting leading industry experts from across Europe, Connect in Pharma...
Mumbai, India - 27 June 2023 - ACG announces full shareholding ownership of Technical Aluminium Foil Company (TAFC)....
CLEVELAND, US - 21 June 2023 - The Lubrizol Corporation announces the licensing of its novel excipient polymer...
Oxford, United Kingdom - 21 June 2023 (GLOBE NEWSWIRE) - Vaccitech plc, a clinical-stage biopharmaceutical company...
CLEVELAND, US - 21 June 2023 - The Lubrizol Corporation announces the licensing of its novel excipient polymer...
Cary, US - 20 June 2023 - Global biopharmaceutical services provider Allucent has partnered with THREAD, an innovative...
Cary, US - 20 June 2023 - Global biopharmaceutical services provider Allucent has partnered with THREAD, an innovative...
Wayne, PA - TekniPlex Healthcare, which utilizes advanced materials science expertise to help deliver better patient...
16 June 2023 -- Malmˆ, Sweden -- Ascelia Pharma AB, a biotech focused on improving the life of people living with rare...
Holland, US - TekniPlex, a globally integrated provider of innovative solutions through materials science and...
CLEVELAND, US - 21 June 2023 - The Lubrizol Corporation announces the licensing of its novel excipient polymer technology, Apisolex excipient, to Welton Pharma (Welton). The license allows Welton to use the Apisolex excipient worldwide to develop and commercialise a...
Cary, US - 20 June 2023 - Global biopharmaceutical services provider Allucent has partnered with THREAD, an innovative decentralised clinical trial (DCT) and electronic clinical outcomes assessment (eCOA) technology provider, to launch Allucent Patient Direct Trials....
Southborough, US - 12 June 12 2023 - Veristat, a scientific-minded global clinical research organization (CRO), has acquired Scinopsis, a European medical writing consultancy with a 17-year track record of delivering regulatory and medical communication documents of...